Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SI-BONE, Inc.SIBN · Entity 2501 | Director | October 01, 2026 | October 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SI-BONE, Inc.
Report date October 01, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,057 |
Reported balance
After 2026-10-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-01 · Exercise / conversion · Acquired 20,000 · Balance 36,057 |
| Common StockSEC Table I · non-derivative | Direct | 16,057 |
Reported balance
After 2026-10-01 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-10-01 · Sale · Disposed 20,000 · Balance 16,057 F1: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated May 7th, 2025. F2: This transaction was executed in multiple trades at prices ranging from $18.28 USD to $18.96 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: Includes 10,957 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.68 · Expires 2027-03-01 | Direct | 66,260 |
Reported balance
After 2026-10-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-10-01 · Exercise / conversion · Disposed 20,000 · Balance 66,260 F5: The shares subject to the option vest in equal monthly installments over four years commencing on the vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. |
| Common StockSEC Table I · non-derivative | Indirectby Trust | 81,073 |
Reported balance
Holding disclosure · report date 2026-10-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 81,073 F4: Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated May 7th, 2025.
F2: This transaction was executed in multiple trades at prices ranging from $18.28 USD to $18.96 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: Includes 10,957 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F4: Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012.
F5: The shares subject to the option vest in equal monthly installments over four years commencing on the vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 16, 2020 Filed Jul 17, 2020 16:50 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,475 | $16.56 | $24,429.25 |
DisclosureSEC source: 0001562180-20-005154 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,156 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · balance_after: Includes 194,953 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 03, 2020 Filed Jun 5, 2020 20:48 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 30,000 | $18.25 | $547,467.00 |
DisclosureSEC source: 0001562180-20-004302 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 355,940 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $17.88 to $18.65, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012. Read SEC document |
| May 18, 2020 Filed May 19, 2020 21:13 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 4,673 | $16.75 | $78,276.49 |
DisclosureSEC source: 0001562180-20-003736 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,631 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · balance_after: Includes 199,210 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on share of the Issuer's common stock. Read SEC document |
| March 26, 2020 Filed Mar 30, 2020 21:42 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-002754 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,304 F1 · shares: Reflects shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. The shares subject to the restricted stock unit vest in lump sum on January 15, 2021, subject to the Reporting Person's continued service through relevant vesting date. F2 · balance_after: Includes 217,041 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock. Read SEC document |
| February 11, 2020 Filed Feb 12, 2020 21:16 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,140 | $21.21 | $24,179.40 |
DisclosureSEC source: 0001562180-20-001107 · primarydocument.xml · nonDerivative · entry 2 DUNN JEFFREY W · CIK 0001035986 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 385,940 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F4 · balance_after: Includes 212,541 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:16 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 18,860 | $21.13 | $398,521.23 |
DisclosureSEC source: 0001562180-20-001107 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 387,080 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $21.00 to $21.29, inclusive. F3 · balance_after: Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012. Read SEC document |
| January 28, 2020 Filed Jan 30, 2020 22:24 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,600 | $23.00 | $36,801.92 |
DisclosureSEC source: 0001562180-20-000702 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 405,940 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $23.00 to $23.01, inclusive. F3 · ownership.nature: Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012. Read SEC document |
| January 15, 2020 Filed Jan 17, 2020 21:29 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,743 | $21.31 | $37,143.85 |
DisclosureSEC source: 0001562180-20-000427 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,804 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · balance_after: Includes 212,541 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock. Read SEC document |
| January 10, 2020 Filed Jan 14, 2020 22:08 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 20,000 | $21.55 | $430,992.00 |
DisclosureSEC source: 0001562180-20-000373 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 407,540 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $21.07 to $22.02, inclusive. F3 · ownership.nature: Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 20:51 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 144,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-000264 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,547 F1 · shares: Reflects shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. The shares subject to the restricted stock unit will be vesting over four years beginning on January 1, 2020 and will be released in quarterly installments commencing on May 15, 2020, subject to the Reporting Person's continued service through each relevant vesting date. F2 · balance_after: Includes 216,797 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock. Read SEC document |
| November 05, 2019 Filed Nov 6, 2019 22:12 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 37,400 | $19.17 | $717,025.32 |
DisclosureSEC source: 0001562180-19-005378 · primarydocument.xml · nonDerivative · entry 2 DUNN JEFFREY W · CIK 0001035986 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 427,540 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F4 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.00 to $19.28, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 22:12 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,600 | $19.01 | $49,414.04 |
DisclosureSEC source: 0001562180-19-005378 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 464,940 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.00 to $19.01, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012. Read SEC document |
| October 18, 2019 Filed Oct 18, 2019 20:44 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 5,775 | $15.57 | $89,925.41 |
DisclosureSEC source: 0001562180-19-005189 · primarydocument.xml · nonDerivative · entry 2 DUNN JEFFREY W · CIK 0001035986 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,747 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · balance_after: Includes 71,997 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock. Read SEC document |
| October 16, 2019 Filed Oct 18, 2019 20:44 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,475 | $15.82 | $23,335.98 |
DisclosureSEC source: 0001562180-19-005189 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,522 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| September 16, 2019 Filed Sep 18, 2019 23:40 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 25,497 | $19.08 | $486,398.62 |
DisclosureSEC source: 0001562180-19-004873 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 467,540 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.00 to $19.2061, inclusive. F3 · ownership.nature: Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012. Read SEC document |
| September 13, 2019 Filed Sep 16, 2019 16:29 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 14,503 | $19.16 | $277,931.14 |
DisclosureSEC source: 0001562180-19-004811 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 493,037 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.00 to $19.49, inclusive. F3 · balance_after: Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012. F3 · ownership.nature: Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012. Read SEC document |
| August 16, 2019 Filed Aug 19, 2019 20:10 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 40,000 | $19.64 | $785,740.00 |
DisclosureSEC source: 0001562180-19-004347 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 507,540 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.00 to $20.00, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012. Read SEC document |
| July 18, 2019 Filed Jul 19, 2019 18:04 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,436 | $20.16 | $28,947.75 |
DisclosureSEC source: 0001562180-19-004000 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,997 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · balance_after: Includes 92,920 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 23:42 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantStock Option (right to buy) · Derivative | 147,500 | $0.00 Strike: $22.00 | $0.00 |
DisclosureSEC source: 0001209191-19-004388 · doc4.xml · derivative · entry 3 DUNN JEFFREY W · CIK 0001035986 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,500 Underlying: Common Stock · 147,500 shares Expires 2029-01-15 F3 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on January 15, 2019, subject to the Reporting Person's continued service through each relevant vesting date. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 23:42 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 68,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-004388 · doc4.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,433 F1 · shares: Reflects shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. The restricted stock unit will vest in equal quarterly installments over four years commencing on January 15, 2019, subject to the Reporting Person's continued service through each relevant vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.